Akorn Expands Commercialization Agreement With Indian Partner Natco
This article was originally published in PharmAsia News
Executive Summary
Akorn has expanded a purchase and supply agreement it struck in March with Natco Pharma Limited to commercialize generic oncology products, the company announced Nov. 27